Free Trial

Bullfrog AI (BFRG) Competitors

Bullfrog AI logo
$2.34 +0.22 (+10.38%)
Closing price 04:00 PM Eastern
Extended Trading
$2.46 +0.13 (+5.34%)
As of 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BFRG vs. ANL, AVTE, PMVP, AVTX, UNCY, VIGL, CLSD, ANIX, FBLG, and GALT

Should you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include Adlai Nortye (ANL), Aerovate Therapeutics (AVTE), PMV Pharmaceuticals (PMVP), Avalo Therapeutics (AVTX), Unicycive Therapeutics (UNCY), Vigil Neuroscience (VIGL), Clearside Biomedical (CLSD), Anixa Biosciences (ANIX), FibroBiologics (FBLG), and Galectin Therapeutics (GALT). These companies are all part of the "pharmaceutical products" industry.

Bullfrog AI vs.

Bullfrog AI (NASDAQ:BFRG) and Adlai Nortye (NASDAQ:ANL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

Adlai Nortye has a consensus target price of $9.00, indicating a potential upside of 346.65%. Given Adlai Nortye's stronger consensus rating and higher possible upside, analysts clearly believe Adlai Nortye is more favorable than Bullfrog AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Adlai Nortye
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Bullfrog AI has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500. Comparatively, Adlai Nortye has a beta of -1.38, meaning that its stock price is 238% less volatile than the S&P 500.

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 35.2% of Adlai Nortye shares are held by institutional investors. 33.9% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Adlai Nortye's average media sentiment score of 1.95 beat Bullfrog AI's score of 0.00 indicating that Adlai Nortye is being referred to more favorably in the news media.

Company Overall Sentiment
Bullfrog AI Neutral
Adlai Nortye Very Positive

Bullfrog AI has higher earnings, but lower revenue than Adlai Nortye.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bullfrog AI$60K339.69-$5.36M-$0.85-2.75
Adlai Nortye$5M14.87-$104.87MN/AN/A

Adlai Nortye's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Bullfrog AIN/A -141.39% -124.63%
Adlai Nortye N/A N/A N/A

Adlai Nortye received 8 more outperform votes than Bullfrog AI when rated by MarketBeat users.

CompanyUnderperformOutperform
Bullfrog AIN/AN/A
Adlai NortyeOutperform Votes
8
100.00%
Underperform Votes
No Votes

Summary

Adlai Nortye beats Bullfrog AI on 9 of the 13 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRG vs. The Competition

MetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$20.38M$6.57B$5.40B$9.13B
Dividend YieldN/A2.96%5.37%4.00%
P/E Ratio-2.759.9288.5817.53
Price / Sales339.69335.061,285.6980.43
Price / CashN/A22.6336.6032.90
Price / Book5.445.074.964.69
Net Income-$5.36M$154.90M$117.96M$224.57M
7 Day Performance11.43%2.53%2.55%3.32%
1 Month Performance11.96%1.43%3.50%5.32%
1 Year Performance-52.15%5.46%27.04%22.98%

Bullfrog AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRG
Bullfrog AI
0.256 of 5 stars
$2.34
+10.4%
N/A-56.6%$20.38M$60,000.00-2.754High Trading Volume
ANL
Adlai Nortye
2.0636 of 5 stars
$1.98
-0.5%
$9.00
+354.5%
-76.5%$73.06M$5M0.00127Positive News
Gap Up
AVTE
Aerovate Therapeutics
1.0757 of 5 stars
$2.50
-2.0%
$2.25
-10.0%
-87.3%$72.19MN/A-0.8420Positive News
PMVP
PMV Pharmaceuticals
2.2559 of 5 stars
$1.39
-4.8%
$5.50
+295.7%
-14.9%$71.93MN/A-1.3950
AVTX
Avalo Therapeutics
4.052 of 5 stars
$6.87
-1.9%
$40.00
+482.2%
+60.3%$71.41M$820,000.000.0040
UNCY
Unicycive Therapeutics
3.4105 of 5 stars
$0.69
+3.3%
$5.50
+701.4%
-28.4%$71.24M$680,000.00-0.719Positive News
VIGL
Vigil Neuroscience
3.9996 of 5 stars
$1.74
-2.8%
$19.75
+1,035.1%
-32.5%$71.13MN/A-0.8440
CLSD
Clearside Biomedical
3.3256 of 5 stars
$0.93
-5.1%
$5.33
+473.7%
-27.9%$70.51M$7.70M-2.0730Positive News
ANIX
Anixa Biosciences
3.4858 of 5 stars
$2.19
-2.7%
$8.50
+288.1%
-51.4%$70.47M$210,000.00-5.625Gap Up
FBLG
FibroBiologics
1.9205 of 5 stars
$2.00
+6.4%
$13.00
+550.0%
N/A$70.17MN/A0.0010
GALT
Galectin Therapeutics
2.1447 of 5 stars
$1.11
+0.9%
$11.00
+891.0%
-29.1%$69.67MN/A-1.529Positive News

Related Companies and Tools


This page (NASDAQ:BFRG) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners